Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.

about

Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study.Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study

P2860

Q48233579-B576D655-AC72-43C9-8C2C-85930F61B2BF Q58797068-42E32EA3-A580-421E-B56A-07DC94DE9C9C

P2860

Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.

Item

http://www.wikidata.org/entity/Q39344669

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Persistence with denosumab and ...... population-based cohort study.

@en

Persistence with denosumab and ...... population-based cohort study.

@nl

type

Item

label

Persistence with denosumab and ...... population-based cohort study.

@en

Persistence with denosumab and ...... population-based cohort study.

@nl

prefLabel

Persistence with denosumab and ...... population-based cohort study.

@en

Persistence with denosumab and ...... population-based cohort study.

@nl

P1476

Persistence with denosumab and ...... population-based cohort study.

@en

P2093

Marc Dorais

http://www.w3.org/2001/XMLSchema#string

Sylvie Perreault

http://www.w3.org/2001/XMLSchema#string

Éric Tremblay

http://www.w3.org/2001/XMLSchema#string

P2860

Bisphosphonates for the prevention and treatment of osteoporosis

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis.

The validity of administrative data to identify hip fractures is high--a systematic review.

Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study.

Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada

Validation of diagnostic codes within medical services claims.

Osteoporosis medication prescribing in British Columbia and Ontario: impact of public drug coverage.

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis

P2888

s11657-016-0282-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11657-016-0282-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27679503

http://www.w3.org/2001/XMLSchema#string

Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.

about

P2860

P2860

Persistence with denosumab and zoledronic acid among older women: a population-based cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P698